AHSCT generally indicated for SSc-aggressive disease portending poor prognosis, early dcSSc with internal organ involvement when expected survival rate only 50% at 5 years. Careful selection of patients with poor prognosis but lack advanced organ involveme
769 followers
347 followers
Fantastic review of State-of-the-art Treatments in #SystemicSclerosis by Dr. @Janetbirdope & colleagues
29 followers
RT @NatRevRheumatol: Thank you to @Janetbirdope for a great presentation on #systemicsclerosis treatment at #SScWorldCongress 'Best of Jour…
19,206 followers
RT @NatRevRheumatol: Thank you to @Janetbirdope for a great presentation on #systemicsclerosis treatment at #SScWorldCongress 'Best of Jour…